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Abstract 
To compare the efficacy and safety of intravaginal administration of misoprostol  alone versus misoprostol 
and  isosorbide mononitrate for cervical ripening and labour induction. One hundred women with term 
gestation, Bishop score <4 with various indications for labour induction were randomly divided into two 
groups. In Group I, 50 µg of misoprostol tablet was placed intravaginally, 4 hourly maximum upto 4 doses. 
In Group II,50 µg of misoprostol tablet with 40mg of isosorbide mononitrate was placed intravaginally in 
posterior fornix upto 4 doses. Two groups were similar in their clinical characteristics. The induction to 
delivery interval was 20.8±2.9 hours vs 14.2±2.7 hours in two groups respectively. Misoprostol and 
isosorbide mononitrate was associated with a shorter induction to delivery interval, decreased oxytocin 
requirement higher rate of vaginal delivery i.e 62.8% Vs 53.9% . Uterine hyperstimulation was more 
common with misoprostol. Neonatal outcome was similar in both the groups. The present study suggests 
that both intravaginal misoprostol and combination of isosorbide mononitrate and misoprostol are safe and 
effective modes of labour induction. Isosorbide mononitrate and misoprostol is more effective than 
misoprostol alone in terms of  shorter induction to active phase interval and induction to delivery interval. 
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Introduction 
Induction of labour is now an integral part of 
modern day obstetrics. Several factors influence 
the outcome of induced labour. Unfavourable cervix 
is one of the main cause of failed induction, in 
order to overcome this cervix need to be ripened. 
Cervical ripening is an active process resembling an 
inflammatory reaction, which involves a complex 
cascade of degradative enzymes accompanied by 
degradation and disorganization of the collagen 
framework, an increased water content, and 
rearrangement of extracellular matrix proteins and  
glycoproteins [1,2]. Induction of labour with an 
unripe cervix is the main cause of induction failure 
and caesarean delivery. [3]Cervical ripening agents 
are routinely used in women with anunfavourable 
cervix which is often defined as Bishops score  
of ≤6. Ripening of the cervix may be achieved by 
both pharmacological and non-pharmacological 
(mechanical) methods [4]. Since the late 1960s 
prostaglandins (PG) have been used for the 
induction of labour at term. However, in the last 
years, there has been a considerable interest in the 
use of misoprostol [5,6,7]  and nitric oxide  
(NO) donors [8,9]  for cervical ripening and  
labour induction. Isosorbide mononitrate facilitate 
the production of nitric oxide to induce cervical 
ripening [10]. No donors may be such agent as  
they relax the myometrium while inducing 
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cervical ripening. To the best of our knowledge, data 
regarding use of vaginal isosorbide mononitrate 
(IMN) and misoprostol for cervical ripening  
are limited and conflicting. Thus the present  
study was conducted to evaluate the efficacy  
and safety of intravaginal administration of 
misoprostol with isosorbide mononitrate  
versus  misoprostol alone  for cervical ripening 
and labour induction. 
Materials and Methods  
This prospective clinical study was conducted 
in the Department of Obstetrics and Gynaecology in 
collaboration with the Department of Paediatrics, 
J.N.M.C.H., A.M.U., Aligarh (U.P.) India during 
Sep 2014-Oct 2015. The included criteria were 
singleton pregnancy with cephalic presentation, 
gestation age> 37 weeks on the basis of LMP or 
first trimester ultrasonography, intact membranes, 
unfavourable cervix (Bishop score ≤ 4), need 
pregnancy termination for fetal or maternal 
indication. Women were excluded from the study 
if any of the following criteria were encountered: 
rupture of membranes, chorioamnionitis, antepartum 
haemorrhage, cervical dilation >2.5 cm, temperature 
>38ºC, contracted pelvis, fetal distress, 
polyhydramnios, indication for immediate delivery 
and previous caesarean section or other uterine 
surgery .One hundred women requiring indicated 
induction of labour with an unfavourable cervix 
(Bishop score ≤ 4) were included in the study. 
They were randomly divided into two groups. At 
first, the method of the study was completely 
explained to them if the written consent was 
obtained, they were enrolled in the study. This 
study was approved by the ethics committee of 
Faculty of medicine Aligarh Muslim University. 
Cases were selected from antenatal clinic (ANC), 
outpatient department (OPD) and patients admitted 
in the hospital. Demographic and clinical data 
were collected at routine antenatal visits. The two 
groups were comparable with respect to maternal 
age, parity, gestational age and preinduction 
Bishop score. In Group I, 52 women induced with 
50 µg of misoprostol tablet which was placed 
intravaginally 6 hourly maximum upto 4 doses. In 
Group II, 50 µg of misoprostol tablet with 40 mg of 
isosorbide mononitrate was placed intravaginally 
in posterior fornix upto 4 doses. Patients was 
reevaluated after 6 hrs of initial application and 
based on the clinical response  either no medication 
or a second dose of 50 µg of misoprostol or 40 mg 
isosorbide mononitrate and 50 µg of misoprostol 
was given in the two study respectively. The dose 
of drug was repeated every 6 hour until 3 or more 
uterine contractions of 40 secs duration occurred 
over 10 min or when the maximum of 4 doses 
(200 µg+160 mg) was reached. If there was no 
effective uterine contractions or patients not 
entering into active phase 6hrs after the fourth 
dose  then it was considered as failure of induction 
and patient was taken up for caesarean section. 
Patient monitoring of fetal heart sound was done 
clinically or by cardiotocography. Fetal heart rate 
and uterine activity monitoring was done in 
accordance with the departmental protocol for 
induction of labor. Maternal pulse rate and  
blood pressure was taken every 30 mints during  
2 hrs after initiation of treatment Augmentation 
was done either by artificial membrane rupture  
or oxytocin drip, whichever is indicated.  
Oxytocin drip (2.5 or 5 IU in 500 ml of Ringer’s 
lactate solution) was started then and it was 
titrated according to frequency and intensity of 
uterine contractions. An oxytocin infusion was 
started at 2 mU/min and increased in increments of  
l-2 mU/min at 15-30-min intervals as needed  
to achieve an adequate contraction pattern. 
Maternal demographic profile, labour and delivery 
characteristics, adverse maternal effects and 
neonatal outcomes were examined. Data was 
analysed using SPSS software. 
Results 
In the present study, one hundred pregnant 
women with indication for induction were evaluated. 
They were randomly divided into two groups.  
52 women induced with intravaginal misoprostol 
as Group I and 48 women induced with isosorbide 
mononitrate and misoprostol as Group II. Maternal 
baseline characterstics were similar between the 
two groups in terms of age, parity, gestational age 
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and preinduction Bishop score (Table 1). The two 
groups were comparable with respect to indications 
for induction of labour (Table 2). Post induction 
Bishop score in two groups was 4.4 ± 1.6 and  
8.2 ± 2.4 respectively. The Induction to active phase 
interval  was 8.6±1.7 hours in misoprostol group 
and 5.6±1.7 hours in isosorbide mononitrate group 
and it was significantly shorter in group II. Oxytocin 
for labour augmentation was needed in 23.1% 
versus 22.9% and artificial rupture of membrane 
(ARM) was required in 50% versus 52.1% women 
in the two groups respectively. Induction to 
delivery interval  was 20.8±2.9 hours in 
misoprostol group and 14.2±2.7 hours in 
isosorbide mononitrate plus misoprostol group and 
it was significantly shorter in group II.Vaginal 
delivery in misoprostol group was 53.9% and in 
isosorbide mononitrate and misoprostol group was 
62.5%.The caesarean section rate was 46.1% in 
group I and 37.5% in group II, the  mode of 
delivery was statistically non significant between 
the  two groups Among the uterine contractile 
abnormalities the incidence of  hyperstimulation 
was 3.8%  in misoprostol group compared to 2.1%  
in isosorbide mononitarte and misoprostol  group. 
There were no case of uterine tachsystole 
orhypertonus in both the study groups. 
Hypotension and tachycardia was reported in 4.1% 
women in isosorbide mononitrate and misoprostol 
group, and headache and flushing was reported  
in 2.1% women in isosorbide mononitrate  
and misoprostol group, while 5.7% women 
developed diarrhoea in misoprostol group.  
These maternal complications were statistically 
not significant in two groups as shown in  
Table 4.The birth weight was 2.84±0.44 and 
2.87±0.42 in the two groups respectively.  
Apgar score at 1 minute was 7.3±1.5 versus 
8.4±1.2 and at 5 minutes was 8.9 ± 0.4 versus 
9.0±0.0 in both the groups respectively.  
NICU admission was 5.8% and 2.1% and 
meconium aspiration syndrome was noticed  
in 5.7% versus 2% in group I and group II 
respectively. Respectively but none of  
the neonate had any features suggestive of  
neonatal sepsis in either group (Table 5). 
 
Table 1. Demographic profile of the study subjects 
Parameters 









Age (years)  
(Mean ±SD) 
25.40 ± 4.3 24.10 ± 2.7 >0.05 
Gravidity 
Primi 46.1% 52.1% >0.05 
Multi 53.9% 47.9% >0.05 
Gestational age 
(weeks) (Mean ±SD) 
39.0 ± 1.58 38.79 ± 1.60 >0.05 
Preinduction 
Bishop Score 
2.4 ± 1.2 2.1 ± 1.2 >0.05 
Table 2. Indication for induction of labour 









>40weeks 28(53.8) 19(39.5) >0.05 
Oligohydramnios 06(11.5) 04(8.3) >0.05 
Preeclampsia 09(17.3) 12(25.0) >0.05 
Intrauterine Growth 
Restriction 
03(5.8) 01(02.1) >0.05 
Gestational  Diabetes 
Mellitus 
02(03.9) 03(06.3) >0.05 
Gestational Pruritis 01(1.9) 03(6.3) >0.05 
Others 03(5.8) 06(12.5) >0.05 
Total 52(100) 48(100) - 














4.4 ± 1.6 8.2 ± 2.4 <0.001 
Induction to active 
phase interval  
(Mean ± SD) (hrs) 
8.6 ± 1.7 5.6 ± 1.7 <0.001 
Augmentation Required - - - 
Oxytocin drip 23.1% 22.9% >0.05 
Oxytocin + ARM 50.0% 52.1% >0.05 
ARM 26.9% 25.0% >0.0 
Induction to delivery 
interval (Mean ± SD) (hrs) 
20.8 ± 2.9 14.2 ± 2.7 <0.001 
Mode of 
Delivery 
Vaginal 53.9% 62.5% >0.05 
Caesarean 46.1% 37.5% >0.05 
Table 4. Uterine contractile abnormalities and 













Tachysystole 0 0 - 
Hypertonus 0 0 - 
Hyperstimulation 2 1 >0.05 
Maternal Side 
Effects    
Flushing - 1 >0.05 
Hypotension - 2 >0.05 
Tachycardia - 2 >0.05 
Headache - 1 >0.05 
Diarrhoea 3 - >0.05 
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Birth weight (kg) 
(Mean ± SD)  
2.84 ± 0.44 




Apgar score  
(at 1 min) 
Mean ± SD 
7.3 ± 1.5 




Apgar score  
(at 5 min) 
Mean ± SD  
8.9 ± 0.4 























Induction of labour is an integral component 
of maternity practice and is  frequently indicated 
for a variety of obstetric, medical, and social 
conditions. In this study the two groups were 
comparable in their demographic profile, preinduction 
Bishop score and indication for induction of labour. 
There is statistically significant difference in the 
postinduction Bishop score in both the groups 
DaveAnupama et al. [11] and Hamideh et al. [12] 
also found significant changes in the mean of 
Bishop score before and after IMN (1.94 ± 1.3 Vs 
6.7±2.2) but differ from Wolfler MM, et al. [13] 
who found that vaginally administered IMN does 
not play a role in promoting delivery in pregnancy 
if given at the same time as dinoprostone. The 
results of the current study are not comparable 
because we use misoprostol instead of dinoprostone. 
Our findings are in consistence with Ahmed T 
Soliman [14] and Mohamad S. Abdellah [15] who 
demonstrated that the combination of IMN and 
misoprostol is more effective for cervical ripening 
than either IMN or misoprostol alone and results 
in a shorter latent phase of labour. The current 
study shows that the induction to delivery interval 
was significantly shorter in IMN and misoprostol 
group as compared to misoprostol alone  group 
(14.2 ± 2.7 hours Vs 20.8 ± 2.9 hours, p < 0.001). 
The shorter induction to delivery interval in IMN 
and misoprostol group could be explained on the 
basis of synergistic effect on cervix via vaginal 
route due to direct access to cervix by cervical 
canal.  Our results were in contrast with Justin P. 
Collingham, [16] as they did not show a benefit in 
the addition of vaginal isosorbide mononitrate to 
an oral misoprostol protocol for cervical ripening 
and labour induction in terms of reducing the 
length of time to vaginal delivery. The difference in 
the results could be due to   route of administration 
of misoprostol as we have used vaginal in our 
study group as compared to oral misoprostol in 
their study. They chose to use oral misoprostolto 
eliminate the potential for pharmacologic interaction 
between vaginal misoprostol and vaginal isosorbide 
mononitrate. The lack of synergy between oral-
misoprostol and vaginal isosorbide  mononitrate 
may be a result of this effect.  
Our findings are in agreement with the study 
of Ramya Krishnamurthy [17] as she also noted 
that the need for oxytocin was less in IMN group 
when compared to placebo group but statistically 
this also proved to be insignificant. misoprostol) 
but not in harmony with Abdul Razaq [18] 
regarding oxytocin need there is significant 
decrease in use of oxytocin for initiation or 
augmentation of labour ifmisoprostol was used for 
cervical ripening as it lead to development of 
uterine contractions. The mode of delivery was 
statistically non significant in two groups [14,16]. 
Uterine contractile abnormalities were more 
common in misoprostol group while nil in IMN 
and misoprostol group groups [15] here was no 
case of hyperstimulation in the IMN group in the 
study done by Habib et al. [19] but a higher 
incidence of tachysystole  was observed in the 
IMN group which disagrees with our results.  
Maternal haemodynamic complications were more 
common in IMN and misoprostol group compared 
to misoprostol alone group and similar findings 
have also been reported by Kavita Agarwal[20] due 
to vasodilatory effect of nitric oxide donors. 
Statistically there was no significant difference 
in the birth weight but the Apgar score between 
the two groups at 1 minute is statistically 
significant which is in harmony with the results 
reported by Abdul Razaq [18].  
Conclusion  
The present study suggests that both 
intravaginal misoprostol and combination of 
isosorbide mononitrate and misoprostol are safe 
and effective modes of labour induction. 
Isosorbide mononitrate and misoprostol is more 
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effective than misoprostol alone in terms of post 
induction Bishop Score, shorter induction to active 
phase interval and induction to delivery interval. 
Uterinehyperstimulation is more common  
with misoprostol while isosorbide mononitrate had  
no uterine contractile abnormalities. Isosorbide 
mononitrate and misoprostol is associated with 
better Apgar score at 1 minute and 5 minute 
respectively. Thus the combined use of nitric 
oxide donor (IMN) with misoprostol for 
preinduction cervical ripening at term may  
prove to be a major therapeutic advance.   
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